Rofida Albash
Impact in
- Pharmaceutical Science top 0.5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Dermatology top 5%
- Dermatology and Skin Diseases
Papers in
-
- Advancements in Transdermal Drug Delivery 13
- Advanced Drug Delivery Systems 8
-
- Dermatology and Skin Diseases 5
- Co-authors
- Mohamed A. El-Nabarawi (5 shared papers)Hanan Refai (3 shared papers)Aly A. Abdelbary (2 shared papers)Mariam Hassan (5 shared papers)Abdulaziz Mohsen Al-mahallawi (2 shared papers)Menna M. Abdellatif (3 shared papers)Shaimaa Mosallam (8 shared papers)Noha M. Badawi (3 shared papers)
- Journals
- Drug Delivery (5 papers)International Journal of Nanomedicine (4 papers)Frontiers in Pharmacology (3 papers)AAPS PharmSciTech (2 papers)Pharmaceuticals (2 papers)
- Partner nations
- EgyptSaudi ArabiaMexico
In The Last Decade
Rofida Albash
26 papers receiving 674 citations
Peers
Comparison fields: 5 of 74
- Pharmaceutical Science 420
- Dermatology 115
- Microbiology 47
- Molecular Medicine 28
- Biomaterials 69
Countries citing papers authored by Rofida Albash
This map shows the geographic impact of Rofida Albash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rofida Albash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rofida Albash more than expected).
Fields of papers citing papers by Rofida Albash
This network shows the impact of papers produced by Rofida Albash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rofida Albash. The network helps show where Rofida Albash may publish in the future.
Co-authors
The 25 scholars most cited alongside Rofida Albash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 120 | |
| 2 | 2019 | 107 | |
| 3 | 2021 | 55 | |
| 4 | 2020 | 51 | |
| 5 | 2021 | 50 | |
| 6 | 2020 | 47 | |
| 7 | 2022 | 35 | |
| 8 | 2022 | 30 | |
| 9 | 2024 | 22 | |
| 10 | 2023 | 22 | |
| 11 | 2023 | 21 | |
| 12 | 2024 | 20 | |
| 13 | 2021 | 19 | |
| 14 | 2023 | 18 | |
| 15 | 2022 | 16 | |
| 16 | 2024 | 12 | |
| 17 | 2025 | 9 | |
| 18 | 2025 | 7 | |
| 19 | 2024 | 6 | |
| 20 | 2025 | 6 |
About Rofida Albash
Rofida Albash is a scholar working on Pharmaceutical Science, Dermatology, Molecular Biology, Biomaterials and Epidemiology, having authored 26 papers that have together received 685 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (13 papers), Advanced Drug Delivery Systems (8 papers), Dermatology and Skin Diseases (5 papers), Nail Diseases and Treatments (3 papers), Bee Products Chemical Analysis (3 papers), Lipid Membrane Structure and Behavior (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Ocular Surface and Contact Lens (2 papers). The work is most often cited by research in Pharmaceutical Science (420 citations), Dermatology (115 citations), Microbiology (47 citations), Molecular Medicine (28 citations) and Biomaterials (69 citations). Rofida Albash has collaborated with scholars based in Egypt, Saudi Arabia and Mexico. Frequent co-authors include Mohamed A. El-Nabarawi, Hanan Refai, Aly A. Abdelbary, Mariam Hassan, Abdulaziz Mohsen Al-mahallawi, Menna M. Abdellatif, Shaimaa Mosallam, Noha M. Badawi, Carol Yousry and Maha M. Abdel‐Fattah. Their work appears in journals such as Drug Delivery, International Journal of Nanomedicine, Frontiers in Pharmacology, AAPS PharmSciTech and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.